Differential mechanisms of angiotensin II and PDGF-BB on migration and proliferation of coronary artery smooth muscle cells

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 2, 2008, Pages 198-208

  Allen, Claire L ^a   Bayraktutan, Ulvi ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antioxidants; Arteries; Atherosclerosis; Nitric oxide; Superoxide anion

Indexed keywords

ANGIOTENSIN II; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANGIOTENSIN II; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CORONARY ARTERY DISEASE; CORONARY VESSELS; HUMANS; MYOCYTES, SMOOTH MUSCLE; OXIDATIVE STRESS; PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 48849083597     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.05.021     Document Type: Article

References (37)

1. Ross R. Atherosclerosis - an inflammatory disease. New Engl J Med 340 (1999) 115-126
2. Grandaliano G., Biswas P., Choudhury G.G., and Abboud H.E. Simvastatin inhibits PDGF-induced DNA synthesis in human glomerular mesangial cells. Kidney Int 44 (1993) 503-508
3. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
4. Shepherd J., Cobbe S.M., Ford I., Isles C.G., Lorimer A.R., MacFalane P.W., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 333 (1995) 1301-1307
5. Campbell M., Allen W.A., Sawyer C., Vanhaesebroeck B., and Trimble E.R. Glucose-potentiated chemotaxis in human vascular smooth muscle is dependent on cross-talk between the PI3K and MAPK signaling pathways. Circ Res 95 (2004) 380-388
6. Holtz J., and Goetz R.M. Vascular renin-angiotensin-system, endothelial function and atherosclerosis?. Basic Res Cardiol 89 (1994) 71-86
7. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril on cardiovascular events in high risk patients. N Engl J Med 342 (2000) 145-153
8. Kohno M., Ohmori K., Nozaki S., Mizushige K., Yasnuari K., Kano H., et al. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells. Hypertension Res 23 (2000) 677-681
9. Griendling K.K., Sorescu D., and Ushio-Fukai M. NADPH oxidase: role in cardiovascular biology and disease. Circ Res 86 (2000) 494-501
10. Bey E.A., and Cathcart M.K. In vitro knockout of human p47-phox blocks superoxide anion production and LDL oxidation by human monocytes. J Lipid Res 41 (2000) 489-495
11. Rubanyi G.M., and Vanhoutte P.M. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 250 (1986) H822-877
12. Yu B.P. Cellular defenses against damage from reactive oxygen species. Physiol Rev 74 (1994) 139-162
13. Molloy C.J., Taylor D.S., and Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem 268 (1993) 7338-7345
14. Huckle W.R., Dy R.C., and Earp H.S. Calcium-dependent increase in tyrosine kinase activity stimulated by angiotensin II. Proc Natl Acad Sci USA 89 (1992) 8837-8841
15. Nadal J.A., Scicli G.M., Carbini L.A., and Scicli A.G. Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF- and PDGF-BB. Am J Physiol 282 (2002) H739-H748
16. Eskilsend-Helmond Y.E., and Mulvany M.J. Pressure-induced activation of extracellular signal-regulated kinase 1/2 in small arteries. Hypertension 41 (2003) 891-897
17. βII. Circ Res 96 (2005) 197-206
18. Zicha D., Dunn G., and Jones G. Analyzing chemotaxis using the Dunn direct-viewing chamber. Methods Mol Biol 75 (1997) 449-457
19. 15N] nitrate in biological fluids. Anal Biochem 126 (1982) 131-138
20. Nickenig G., Sachinidis A., Michaelsen F., Bohm M., Seewald S., and Vetter H. Upregulation of vascular angiotensin II receptor gene expression by LDL in vascular smooth muscle cells. Circulation 95 (1997) 473-478
21. Lo I.C., Shih J.M., and Jiang M.J. Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration. J Biomed Sci 12 (2005) 377-388
22. Kappert K., Sparwel J., Sandin A., Seiler A., Siebolts U., Leppanen O., et al. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis. Arterioscler Thromb Vasc Biol 26 (2006) 2644-2651
23. Campbell M., Allen W.E., Silversides J.A., and Trimble E.R. Glucose-induced phosphatidylinositol 3-kinase and mitogen-activated protein kinase-dependent upregulation of the platelet-derived growth factor-beta receptor potentiates vascular smooth muscle cell chemotaxis. Diabetes 52 (2003) 519-526
24. Mahadevan V.S., Campbell M., McKeown P.P., and Bayraktutan U. Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity. Cardiovasc Res 72 (2006) 60-68
25. Wagner A.H., Kohler T., Ruckschloss U., Just I., and Hecker M. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation. Arterioscler Thromb Vasc Biol 20 (2000) 61-69
26. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
27. Dzau V.J., Braun-Dullaeus R.C., and Sedding D.G. Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8 (2002) 1249-1256
28. Freyhaus H., Huntgeburth M., Wingler K., Schnitker J., Baumer A.T., Vantler M., et al. Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis but not proliferation. Cardiovasc Res 71 (2006) 331-341
29. Bayraktutan U. Nitric oxide synthase and NADPH oxidase enzymes modulate coronary endothelial cell growth. J Mol Cell Cardiol 36 (2004) 277-286
30. Jiang B., Xu S., Hiu X., Pimentel D., and Cohen R.A. Angiotensin II differentially regulates interleukin-1-b-iNOS and VCAM-1 expression. J Biol Chem 279 (2004) 20363-20368
31. Nakata S., Tsutsui M., Shimokawa H., Tamura M., Tasaki H., Morishita T., et al. Vascular neuronal NO synthase is selectively upregulated by platelet-derived growth factor. Arterioscler Thromb Vasc Biol 25 (2005) 2502-2508
32. Bayraktutan U. Coronary microvascular endothelial cell growth regulates expression of the gene encoding p22-phox. Free Rad Biol Med 39 (2005) 1342-1352
33. Bayraktutan U., and Ulker S. Effects of angiotensin II on nitric oxide generation in proliferating and quiescent rat coronary microvascular endothelial cells. Hypertens Res 26 (2003) 749-757
34. Bayraktutan U. Effects of ang II on nitric oxide generation in growing and resting rat aortic endothelial cells. J Hypertens 21 (2003) 2093-2101
35. Parmentier H.J., Zhang C., Estes A., Schaefer S., and Malik K.U. Essential role of PKC-z in normal and angiotensin II-accelerated neointimal growth after vascular injury. Am J Physiol Heart Circ Physiol 291 (2006) H1602-H1613
36. Pelech S.L., and Shanghera J.S. MAP kinases: charting the regulatory pathways. Science 257 (1992) 1355-1356
37. Linseman D.A., Benjamin C.W., and Jones D.A. Convergence of angiotensin II and platelet-derived growth factor receptor signalling cascades in vascular smooth muscle cells. J Biol Chem 270 (1995) 12563-12568